Published in Am J Trop Med Hyg on March 01, 1966
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07
Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol (1999) 3.04
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J Infect Dis (2011) 1.82
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates. Virology (2006) 1.66
Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A (2009) 1.55
Nonsegmented negative-strand viruses as vaccine vectors. J Virol (2006) 1.53
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis (2012) 1.32
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector. Springer Semin Immunopathol (2006) 1.12
Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector. J Virol (2002) 0.97
Nonreplicating vectors in HIV vaccines. Curr Opin HIV AIDS (2013) 0.97
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation. Vaccine (2009) 0.95
Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen. J Virol (2010) 0.94
Cell entry of Borna disease virus follows a clathrin-mediated endocytosis pathway that requires Rab5 and microtubules. J Virol (2009) 0.93
Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates. J Virol (2014) 0.88
Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J Virol (2009) 0.87
Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo. Front Neural Circuits (2013) 0.85
Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo. Int J Interferon Cytokine Mediat Res (2010) 0.84
Acute reactogenicity after intramuscular immunization with recombinant vesicular stomatitis virus is linked to production of IL-1β. PLoS One (2012) 0.83
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. J Infect Dis (2015) 0.82
Cytokine-modified VSV is attenuated for neural pathology, but is both highly immunogenic and oncolytic. Int J Interferon Cytokine Mediat Res (2009) 0.81
Vesicular stomatitis virus enables gene transfer and transsynaptic tracing in a wide range of organisms. J Comp Neurol (2015) 0.80
Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine (2016) 0.76
Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors. J Virol (2015) 0.75
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol (2017) 0.75
Infectious diseases. Annual review of significant publications. Postgrad Med J (1967) 0.75
Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. J Virol (2014) 0.75
Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet (1977) 9.23
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis (1978) 4.95
A plaque neutralization method for arboviruses. Proc Soc Exp Biol Med (1967) 4.27
The child PTSD Symptom Scale: a preliminary examination of its psychometric properties. J Clin Child Psychol (2001) 4.00
Marburg-virus disease in Kenya. Lancet (1982) 3.79
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog Med Virol (1967) 3.22
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am J Epidemiol (1969) 2.91
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
Dissolved organic matter and heterotrophic microneuston in the surface microlayers of the north atlantic. Science (1976) 2.54
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis (1982) 2.42
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis (1980) 2.30
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Venezuelan equine encephalitis. Adv Vet Sci Comp Med (1974) 2.12
Immune tolerance in Calomys callosus infected with Machupo virus. Nature (1969) 2.00
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
Arenoviruses in Vero cells: ultrastructural studies. J Virol (1970) 1.91
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Morphological comparison of Machupo with lymphocytic choriomeningitis virus: basis for a new taxonomic group. J Virol (1969) 1.82
The measurement of specific antibodies in Bolivian hemorrhagic fever by neutralization of virus plaques. Proc Soc Exp Biol Med (1969) 1.82
Arenoviruses: proposed name for a newly defined virus group. J Virol (1970) 1.81
Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ (1979) 1.80
Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol (1996) 1.69
Intraocular use of rituximab. Eye (Lond) (2007) 1.58
Ebola virus: identification of virion structural proteins. J Gen Virol (1980) 1.54
Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa. Bull World Health Organ (1977) 1.53
Chronic infection of rodents by Machupo virus. Science (1965) 1.52
Ecologic studies of vesicular stomatitis virus. I. Prevalence of infection among animals and humans living in an area of endemic VSV activity. Am J Epidemiol (1969) 1.52
Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus. J Infect Dis (1973) 1.50
A percutaneous method for venovenous bypass in liver transplantation. Transplantation (1994) 1.44
Vesicular stomatitis virus (Indiana serotype): transovarial transmission by phlebotomine sandlies. Science (1972) 1.42
Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem (1988) 1.42
The binding of staphylococcal protein A by the sera of different animal species. J Immunol (1982) 1.40
Epidemiology of Machupo virus infection. 3. Significance of virological observations in man and animals. Am J Trop Med Hyg (1965) 1.39
An exotic viral disease acquired in a laboratory. N Engl J Med (1995) 1.38
An outbreak of Venezuelan equine encephalomeylitis in Central America. Evidence for exogenous source of a virulent virus subtype. Am J Epidemiol (1971) 1.37
Recovery of Venezuelan equine encephalomyelitis virus in Panama. A fatal case in man. Am J Trop Med Hyg (1968) 1.35
The circular, segmented nucleocapsid of an arenavirus-Tacaribe virus. J Gen Virol (1977) 1.32
Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg (1986) 1.31
Physician knowledge and attitudes about cancer pain management: a survey from the Minnesota cancer pain project. J Pain Symptom Manage (1995) 1.28
Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience (2001) 1.28
Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. J Clin Microbiol (1981) 1.27
HCF-1 amino- and carboxy-terminal subunit association through two separate sets of interaction modules: involvement of fibronectin type 3 repeats. Mol Cell Biol (2000) 1.26
Mechanism of action of rab3A in mossy fiber LTP. Neuron (1998) 1.24
Lassa fever: response to an imported case. N Engl J Med (1977) 1.23
Bolivian hemorrhagic fever. A report of four cases. Am J Med (1966) 1.23
Hantaan-like viruses from domestic rats captured in the United States. Am J Trop Med Hyg (1984) 1.22
Isolation of Machupo virus from wild rodent Calomys callosus. Am J Trop Med Hyg (1966) 1.21
Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci (1990) 1.21
Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J Infect Dis (1982) 1.20
A human case of encephalitis associated with vesicular stomatitis virus (Indiana serotype) infection. Am J Trop Med Hyg (1988) 1.19
Imported Lassa fever--reexamining the algorithms. N Engl J Med (1990) 1.18
Development of Toxoplasma oocysts in neotropical felidae. Am J Trop Med Hyg (1972) 1.18
Arenaviruses. Intervirology (1974) 1.18
Some characteristics of Machupo virus, causative agent of Bolivian hemorrhagic fever. Am J Trop Med Hyg (1967) 1.18
Neurobiology of cocaine abuse. Trends Pharmacol Sci (1992) 1.17
A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams. J Infect Dis (1999) 1.17
Laboratory-acquired infections with Hantaan virus, the etiologic agent of Korean hemorrhagic fever. J Infect Dis (1982) 1.16
Macroglossia: a review of the condition and a new classification. Plast Reconstr Surg (1986) 1.16
Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg (1983) 1.16
Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium. Lancet (1984) 1.15
Virion nucleic acid of Ebola virus. J Virol (1980) 1.15
Bolivian hemorrhagic fever. A pathologic description. Arch Pathol (1967) 1.15
A review of Soviet viral hemorrhagic fevers, 1969. J Infect Dis (1970) 1.15
Viruses of the Venezuelan equine encephalomyelitis complex. Experimental infection of Panamanian rodents. Am J Trop Med Hyg (1969) 1.15
Recovery of a Lassa-related arenavirus in Zimbabwe. Am J Trop Med Hyg (1981) 1.14
Standardizing digital photography: it's not all in the eye of the beholder. Plast Reconstr Surg (2001) 1.14
Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet (1979) 1.14
Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA. J Infect Dis (1983) 1.14
Epidemiological significance of Venezuelan equine encephalomyelitis virus in vitro markers. Am J Trop Med Hyg (1982) 1.12
Wavelet packet denoising of magnetic resonance images: importance of Rician noise at low SNR. Magn Reson Med (1999) 1.12
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group. AIDS (1990) 1.10
Antigenic analysis of strains of Ebola virus: identification of two Ebola virus serotypes. J Infect Dis (1983) 1.09
A community study of respiratory infections in the tropics. I. Description of the community and observations on the activity of certain respiratory agents. Am J Epidemiol (1967) 1.07
Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses. Nature (1980) 1.06
Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton. J Med Chem (1998) 1.06
Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis. Clin Exp Immunol (1972) 1.06
Strain and model differences in behavioral outcomes after spinal cord injury in rat. J Neurotrauma (2001) 1.06
An arenavirus isolated from wild-caught rodents (Pramys species) in the Central African Republic. Intervirology (1983) 1.05
An outbreak of Venezuelan encephalitis in man in the Panamá Canal Zone. Am J Trop Med Hyg (1970) 1.05
Ecologic studies of vesicular stomatitis virus. II. Results of experimental infection in Panamanian wild animals. Am J Epidemiol (1970) 1.04
False-positive reporting of Down syndrome on Ohio and New York birth certificates. Genet Epidemiol (1985) 1.03
Parana, a new Tacaribe complex virus from Paraguay. Arch Gesamte Virusforsch (1970) 1.03
Rickettsioses of Central America. Am J Trop Med Hyg (1971) 1.03
Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol (1992) 1.02
Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons. Neuroscience (2004) 1.02
Vesicular stomatitis virus in Panama. Human serologic patterns in a cattle raising area. Am J Epidemiol (1967) 1.01
Pathogenesis of Junin virus infection in the infant hamster. An Microbiol (Rio J) (1968) 1.01
Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency. Blood (1999) 1.00
Differences in tobacco assessment and intervention practices: a regional snapshot. Prev Med (2000) 0.99